Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1558 clinical trials
Study of ATI-2138 in Adult Participants with Moderate to Severe Atopic Dermatitis

This is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.

  • 0 views
  • 23 Jan, 2025
  • 5 locations
Tofacitinib for Immune Skin Conditions in Down Syndrome

People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug …

hair thinning
skin disease
hidradenitis suppurativa
tofacitinib
dermatosis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)

Primary Objectives:To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.To evaluate the time-course of AD and selected atopic comorbidities.

  • 0 views
  • 23 May, 2025
  • 1 location
Prospective Longitudinal Observational Research in Atopic Dermatitis

Atopic dermatitis (AD) is a frequent chronic relapsing inflammatory skin disorder, characterized by intensely itchy eczema. AD usually starts within the first 2 years of life.

atopic dermatitis
dermatitis
asthma
allergic rhinitis
allergic asthma
  • 0 views
  • 24 Nov, 2025
  • 1 location
Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Primary Objectives: To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable. To evaluate the time-course of AD and selected atopic comorbidities.

dermatitis
atopy
phototherapy
  • 0 views
  • 19 Feb, 2024
  • 18 locations
Observational Study of Adult Patients Receiving Dupixent for Atopic Dermatitis (AD)

Primary Objective: To characterize the patients who receive Dupixent (dupilumab) for AD in a real-world setting, with respect to their medical history, socio-demographic and disease characteristics, and prior and concomitant treatments of AD Secondary Objectives: To characterize real-world use patterns of Dupixent for AD (eg, used regimens, reason for initiation …

dermatitis
eczema
atopy
dupilumab
  • 0 views
  • 19 Feb, 2024
  • 20 locations
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

Primary Objective: To explore associations between biomarkers of atopic dermatitis (AD) and: Disease state and time course of AD, Disease state and evolution of selected atopic comorbid conditions, Effectiveness of specific AD treatments.

dermatitis
atopy
  • 0 views
  • 19 Feb, 2024
  • 9 locations
A Pilot Study to Explore the Role of Gut Flora in Eczema

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding eczema.

eczema
  • 0 views
  • 19 Feb, 2024
  • 1 location